Alexander D. Cornet

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 142 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +12

Extubation in neurocritical care patients: the ENIO international prospective study

Raphaël Cinotti, Julio Mijangos, Paolo Pelosi et al. · Intensive Care Medicine · 2022 · 107 citations · Full text

Medicine, Anesthesiology, Neurological Surgery +11

Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study

Massimiliano Greco, Thomas De Corte, Ari Ercole et al. · Intensive Care Medicine · 2022 · 88 citations · Full text

Medicine, Infectious Diseases, Critical Care Medicine +14

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 84 citations · Full text

Medicine, Infectious Diseases, Pediatrics +8

The role of heparin and allied compounds in the treatment of sepsis

Alexander D. Cornet, Ellen G. M. Smit, Albertus Beishuizen et al. · Thrombosis and Haemostasis · 2007 · 76 citations

Medicine, Pharmacology, Pharmacotherapy +17